Across TCGA pan-cancer cohorts, DUSP29 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DUSP29 data layer compared with 11 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher DUSP29 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DUSP29 expression acts as an unfavorable survival marker.

HNSC, LUAD, and SARC are the cancer types where DUSP29 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	III,IV	0.059	0.726	<.001	34	view →
LUAD	OS	Median	II,III,IV	0.141	0.709	<.001	18	view →
SARC	DFS	Median	All	0.094	0.611	.001	9	view →
LIHC	OS	Median	All	0.231	0.690	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: DUSP29 tumor-vs-normal RNA expression · all DUSP29 data types